Tenet Healthcare Corp. (NYSE:THC) is trading up 24.61% versus 12-month low of 14.06 and stands -48.59% lower from its 1-year peak of $34.08. The consensus price target (PT) of $24.81 means that the market expects Company shares to increase by 43.8% in the short run. The sell-side target prices range from $13 to $38. In the last month the stock has moved in price 14.96%, with a one year change of -32.04%. The last trading session volume compares with the 3.43M average and market worth floats around 1.77B.

Tenet Healthcare Corp. (NYSE:THC) gained 1.57% to reach at the trading price of $17.52 as it is set to release its next quarterly earnings report on February 27, 2017. Tenet Healthcare Corp. stock trades in the range of $16.94 to $17.69 before the earnings release. Let’s take a closer look at the current earnings forecast, particularly the things traders should pay close attention to. Earnings per share for the recently concluded quarter is expected to come in at $0.23 a share with $4.96B in revenue.

Tenet Healthcare Corp. (THC) Future Earnings & History

After upcoming fiscal quarter results, all eyes will be on the prospects for the next reporting quarter. Analysts, on average, forecast Tenet Healthcare Corp. to earn $0.43 per share (EPS) on revenue of $4.9B. The EPS consensus range is $0.24-$0.55 on revenue between $4.97B and $4.57B.

While if we look at the Earnings Track Record, Tenet Healthcare Corp. (THC) managed to surpass quarterly earnings per share estimates in 8 of the trailing twelve fiscal quarters, and has a positive trend with an average surprise of 66%. Last time the company reported, Tenet Healthcare Corp. (THC) generated $0.16 in earnings per share, missing the consensus estimate of $0.19. Revenues hit $4.85B in the September 2017 quarter, which was above the consensus $4.78B projection. On the other hand, in the June 2017 quarter the company recorded a net $4.87B revenue with earnings per share of $0.38. Wall Street had anticipated $4.83B and $0.52, respectively. For comparison, there was a revenue of $4.69B and EPS of $0.45 in the September 2016 period.

Tenet Healthcare Corp. (NYSE:THC) Analyst Insights

The buoyancy in the outlook of Tenet Healthcare Corp. (THC) is getting weaker by the somewhat negative sentiment (2.70 on a 5-point scale) that sell-side analysts have provided concerning it. Brokerage firms on the average advocate the company shares as Buy. Mizuho has been covering shares of THC, so it is most recent view is worth a look. In a research note issued on Nov 22, 2016, analysts at downgraded the stock to Underperform from Neutral. Another noteworthy analyst activity was recorded on Nov 10, 2016. Downgraded the stock to Mkt Perform from Outperform.